Intravitreal bevacizumab injection in unrecognised early pregnancy
Authors:
- 17 January 2014
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 28 (4) , 492-494
Abstract
The use of intravitreal vascular endothelial growth factor (VEGF) inhibitor medications has widened considerably to include indications affecting females of reproductive age. We present our experiences following intravitreal injection of bevacizumab during the first trimester of unrecognised pregnancies in four women. All our patients were inadvertently exposed to bevacizumab within the first trimester when placental growth and fetal organogenesis take place. There were three cases of pregnancy without complication and one case of complicated pregnancy in which there was a significant past obstetric history. This case series provides further insights into intravitreal injection of bevacizumab in early pregnancy. There is insufficient information to suggest that such use is safe, nor is there definitive evidence to suggest that it causes harm. We advise that ophthalmologists discuss pregnancy with women of childbearing age undergoing intraocular anti-VEGF injections. Should a woman become pregnant, counselling is needed to explain the potential risks and benefits, and the limited available data relating to the use of these agents in early pregnancy.Keywords
This publication has 11 references indexed in Scilit:
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trialThe Lancet, 2013
- Comparison of the Effect of Unilateral Intravitreal Bevacizumab and Ranibizumab Injection on Diabetic Macular Edema of the Fellow EyeJournal of Ocular Pharmacology and Therapeutics, 2013
- Pregnancy-associated Retinal Diseases and Their ManagementSurvey of Ophthalmology, 2013
- Intravitreal Bevacizumab for a Subfoveal Myopic Choroidal Neovascularization in the First Trimester of PregnancyJournal of Ocular Pharmacology and Therapeutics, 2012
- Intravitreal Administration of Ranibizumab for Idiopathic Choroidal Neovascularization in a Pregnant WomanKlinische Monatsblätter für Augenheilkunde, 2012
- INTRAVITREAL BEVACIZUMAB DURING PREGNANCYRetina, 2010
- Early loss of pregnancy after intravitreal bevacizumab injectionActa Ophthalmologica, 2010
- The effect of intravitreal bevacizumab (avastin) administration on systemic hypertensionEye, 2008
- Exposure to verteporfin and bevacizumab therapy for choroidal neovascularization secondary to punctate inner choroidopathy during pregnancyEye, 2008
- Angiogenic growth factors and hypertensionAngiogenesis, 2004